The scientific and societal uses of global measurements of subsurface velocity

© The Author(s), 2019. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Szuts, Z. B., Bower, A. S., Donohue, K. A., Girton, J. B., Hummon, J. M., Katsumata, K., Lumpkin, R., Ortner, P. B., Phillips, H. E., Rossby, H. T., Shay, L. K., Sun, C., & Todd, R. E. The scientific and societal uses of global measurements of subsurface velocity. Frontiers in Marine Science, 6, (2019): 358, doi:10.3389/fmars.2019.00358.Ocean velocity defines ocean circulation, yet the available observations of subsurface velocity are under-utilized by society. The first step to address these concerns is to improve visibility of and access to existing measurements, which include acoustic sampling from ships, subsurface float drifts, and measurements from autonomous vehicles. While multiple programs provide data publicly, the present difficulty in finding, understanding, and using these data hinder broader use by managers, the public, and other scientists. Creating links from centralized national archives to project specific websites is an easy but important way to improve data discoverability and access. A further step is to archive data in centralized databases, which increases usage by providing a common framework for disparate measurements. This requires consistent data standards and processing protocols for all types of velocity measurements. Central dissemination will also simplify the creation of derived products tailored to end user goals. Eventually, this common framework will aid managers and scientists in identifying regions that need more sampling and in identifying methods to fulfill those demands. Existing technologies are capable of improving spatial and temporal sampling, such as using ships of opportunity or from autonomous platforms like gliders, profiling floats, or Lagrangian floats. Future technological advances are needed to fill sampling gaps and increase data coverage.This work was supported by the National Science Foundation, United States, Grant Numbers 1356383 to ZBS, OCE 1756361 to ASB at the Woods Hole Oceanographic Institution, and 1536851 to KAD and HTR; the National Oceanographic and Atmospheric Administration, United States, Ocean Observations and Monitoring Division and Atlantic Oceanographic and Meteorological Laboratory to RL; Royal Caribbean Cruise Ltd., to PBO; the Australian Government Department of the Environment and Energy National Environmental Science Programme and Australian Research Council Centre of Excellence for Climate Extremes to HEP; and the Gulf of Mexico Research Initiative Grant V-487 to LS

Ocean observations in support of studies and forecasts of tropical and extratropical cyclones

© The Author(s), 2019. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Domingues, R., Kuwano-Yoshida, A., Chardon-Maldonado, P., Todd, R. E., Halliwell, G., Kim, H., Lin, I., Sato, K., Narazaki, T., Shay, L. K., Miles, T., Glenn, S., Zhang, J. A., Jayne, S. R., Centurioni, L., Le Henaff, M., Foltz, G. R., Bringas, F., Ali, M. M., DiMarco, S. F., Hosoda, S., Fukuoka, T., LaCour, B., Mehra, A., Sanabia, E. R., Gyakum, J. R., Dong, J., Knaff, J. A., & Goni, G. Ocean observations in support of studies and forecasts of tropical and extratropical cyclones. Frontiers in Marine Science, 6, (2019): 446, doi:10.3389/fmars.2019.00446.Over the past decade, measurements from the climate-oriented ocean observing system have been key to advancing the understanding of extreme weather events that originate and intensify over the ocean, such as tropical cyclones (TCs) and extratropical bomb cyclones (ECs). In order to foster further advancements to predict and better understand these extreme weather events, a need for a dedicated observing system component specifically to support studies and forecasts of TCs and ECs has been identified, but such a system has not yet been implemented. New technologies, pilot networks, targeted deployments of instruments, and state-of-the art coupled numerical models have enabled advances in research and forecast capabilities and illustrate a potential framework for future development. Here, applications and key results made possible by the different ocean observing efforts in support of studies and forecasts of TCs and ECs, as well as recent advances in observing technologies and strategies are reviewed. Then a vision and specific recommendations for the next decade are discussed.This study was supported by the National Oceanic and Atmospheric Administration and JSPS KAKENHI (Grant Numbers: JP17K19093, JP16K12591, and JP16H01846)

The James Webb Space Telescope Mission

Twenty-six years ago a small committee report, building on earlier studies, expounded a compelling and poetic vision for the future of astronomy, calling for an infrared-optimized space telescope with an aperture of at least $4m$. With the support of their governments in the US, Europe, and Canada, 20,000 people realized that vision as the $6.5m$ James Webb Space Telescope. A generation of astronomers will celebrate their accomplishments for the life of the mission, potentially as long as 20 years, and beyond. This report and the scientific discoveries that follow are extended thank-you notes to the 20,000 team members. The telescope is working perfectly, with much better image quality than expected. In this and accompanying papers, we give a brief history, describe the observatory, outline its objectives and current observing program, and discuss the inventions and people who made it possible. We cite detailed reports on the design and the measured performance on orbit.Comment: Accepted by PASP for the special issue on The James Webb Space Telescope Overview, 29 pages, 4 figure

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Evaluation of fraternal versus identical twin approaches for observation impact assessments: An EnKF-based ocean assimilation application for the Gulf of Mexico

Abstract. Assessments of ocean data assimilation (DA) systems and observing system design experiments typically rely on identical or fraternal twin experiments. The identical twin approach has been recognized as yielding biased impact assessments in atmospheric predictions but these shortcomings are not sufficiently appreciated for oceanic DA applications. Here we present the first direct comparison of the fraternal and identical twin approach in an ocean DA application. We assess the assimilation impact for both approaches in a DA system for the Gulf of Mexico that uses the Ensemble Kalman Filter. Our comparisons show that, despite a reasonable error growth rate in both approaches, the identical twin produces a biased skill assessment overestimating the improvement from assimilating sea surface height and sea surface temperature observations while underestimating the value of assimilating temperature and salinity profiles. Such biases can lead to an undervaluation of some observing assets (in this case profilers) and thus misguided distribution of observing system investments

SEA-COOS: A Model for a Multi-State, Multi-Institutional Regional Observation System

The SouthEast Atlantic Coastal Ocean Observing System (SEA-COOS, www.seacoos.org) is a regional partnership that has initiated an integrated coastal ocean observing system for a four-state (North Carolina, South Carolina, Georgia, and Florida) region of the southeast coastal United States. The long-term intent of SEA-COOS is to establish a regional coastal ocean observing system that will be part of the coastal component of the national Integrated Ocean Observing System (IOOS) envisioned by Ocean.US. SEA-COOS was initiated in September, 2002 with funding from the Office of Naval Research (ONR) as a coordinating and enhancing effort between several existing subregional-scale efforts in the southeast, the Sea Grant Offices from the four states, and a number of federal agencies. This article briefly describes the essential elements of an observing system, the region-wide observations, overlapping circulation models, data management capabilities, and outreach and education activities of SEA-COOS, at present and planned for the coming year. Development of a governance system has also been pursued, and an initial structure is in place for SEA-COOS

Recent advancements in aircraft and in situ observations of tropical cyclones

Observations of tropical cyclones (TC) from aircraft and in situ platforms provide critical and unique information for analyzing and forecasting TC intensity, structure, track, and their associated hazards. This report, prepared for the tenth International Workshop on Tropical Cyclones (IWTC-10), discusses the data collected around the world in TCs over the past four years since the IWTC-9, improvements to observing techniques, new instruments designed to achieve sustained and targeted atmospheric and oceanic observations, and select research results related to these observations.In the Atlantic and Eastern and Central Pacific basins, changes to operational aircraft reconnaissance are discussed along with several of the research field campaigns that have taken place recently. The changes in the use and impact of these aircraft observations in numerical weather prediction models are also provided along with updates on some of the experimental aircraft instrumentation. Highlights from three field campaigns in the Western Pacific basin are also discussed. Examples of in-situ data collected within recent TCs such as Hurricane Ian (2022), also demonstrate that new, emerging technologies and observation strategies reviewed in this report, definitely have the potential to further improve ocean-atmosphere coupled intensity forecasts

The James Webb Space Telescope Mission

Twenty-six years ago a small committee report, building on earlier studies, expounded a compelling and poetic vision for the future of astronomy, calling for an infrared-optimized space telescope with an aperture of at least 4 m. With the support of their governments in the US, Europe, and Canada, 20,000 people realized that vision as the 6.5 m James Webb Space Telescope. A generation of astronomers will celebrate their accomplishments for the life of the mission, potentially as long as 20 yr, and beyond. This report and the scientific discoveries that follow are extended thank-you notes to the 20,000 team members. The telescope is working perfectly, with much better image quality than expected. In this and accompanying papers, we give a brief history, describe the observatory, outline its objectives and current observing program, and discuss the inventions and people who made it possible. We cite detailed reports on the design and the measured performance on orbit